title: Marked benefit with sustained-release niacin therapy in patients with "isolated" very low levels of high-density lipoprotein cholesterol and coronary artery disease.
authors.affiliation: Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana.
authors.forename: C J
authors.initials: CJ
authors.lastname: Lavie
authors.forename: L
authors.initials: L
authors.lastname: Mailander
authors.forename: R V
authors.initials: RV
authors.lastname: Milani
mesh_terms: D008076:Cholesterol, HDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy; D008297:Male; D009525:Niacin / Q000627:therapeutic use*
chemical_list: D008076:Cholesterol, HDL; D003692:Delayed-Action Preparations; D009525:Niacin